Mohammad S, Clowse MEB, Eudy AM, Criscione-Schreiber LG (2018) Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients
How do the potential benefits of GLP-1 agonists in reducing risks of heart and kidney disease compare with the risks of side effects like hypoglycemia or gallbladder disorders, and how should a clinician balance these considerations
Peripheral blood mononuclear cell biomarkers for major depressive disorder: a transcriptomic approach
Someone buying a GLP-1 drug directly for weight loss might pay about the same, or more, depending on which service they choose and whether it offers more support beyond just a prescription
Even though it is described to be a non-essential amino acid, in conditions of high nutrient demands, it becomes essential
Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation